DPP4 and cancer: Some ex vivo data indeed suggest that potential targets of DPP-4/CD26 could interfere with chemokine signaling, and the expression of DPP-4/CD26 seems to be associated with cancer aggressiveness and outcomes, although data may be controversial concerning whether it may promote or inhibit cancer growth (15).